PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients

BACKGROUND: Biomarkers that facilitate the prediction of disease recurrence in head and neck squamous cell carcinoma (HNSCC) may enable physicians to personalize treatment. In the current study, DNA promoter methylation of programmed cell death 1 (PDCD1, PD-1) was evaluated as a prognostic biomarker...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Goltz, Diane, Gevensleben, Heidrun, Dietrich, Joern, Schroeck, Friederike, de Vos, Luka, Droege, Freya, Kristiansen, Glen, Schroeck, Andreas, Landsberg, Jennifer, Bootz, Friedrich, Dietrich, Dimo
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522222/
https://ncbi.nlm.nih.gov/pubmed/28487502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17354
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars